Wellington Management Group LLP lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 20.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 541,450 shares of the company's stock after selling 138,934 shares during the quarter. Wellington Management Group LLP owned approximately 2.99% of Addus HomeCare worth $72,029,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of the business. Quarry LP acquired a new position in Addus HomeCare during the third quarter worth about $28,000. UMB Bank n.a. lifted its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $31,000. Farther Finance Advisors LLC grew its position in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after purchasing an additional 366 shares in the last quarter. Finally, Innealta Capital LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at approximately $44,000. Hedge funds and other institutional investors own 95.35% of the company's stock.
Insider Buying and Selling
In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
ADUS has been the topic of a number of recent research reports. KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They set an "overweight" rating and a $150.00 price objective on the stock. StockNews.com raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Wednesday. Royal Bank of Canada reaffirmed an "outperform" rating and set a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Oppenheimer boosted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. Finally, Stephens raised their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Addus HomeCare presently has an average rating of "Moderate Buy" and an average target price of $131.63.
Check Out Our Latest Analysis on ADUS
Addus HomeCare Price Performance
Shares of ADUS stock traded down $2.06 during trading hours on Wednesday, hitting $120.90. The company had a trading volume of 99,255 shares, compared to its average volume of 130,362. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The company's fifty day moving average is $125.90 and its 200 day moving average is $124.32. The stock has a market capitalization of $2.19 billion, a PE ratio of 28.14, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. During the same period in the prior year, the firm earned $1.03 earnings per share. The firm's revenue was up 7.1% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.